Rachel R Xiang, Yihua Wang, Megan M Shuey, Brigett V Carvajal, Quinn S Wells, Joshua A Beckman, Iris Z Jaffe
{"title":"Development and Implementation of an Integrated Preclinical Atherosclerosis Database.","authors":"Rachel R Xiang, Yihua Wang, Megan M Shuey, Brigett V Carvajal, Quinn S Wells, Joshua A Beckman, Iris Z Jaffe","doi":"10.1161/CIRCGEN.123.004397","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Basic scientists have used preclinical animal models to explore mechanisms driving human diseases for decades, resulting in thousands of publications, each supporting causative inferences. Despite substantial advances in the mechanistic construct of disease, there has been limited translation from individual studies to advances in clinical care. An integrated approach to these individual studies has the potential to improve translational success.</p><p><strong>Methods: </strong>Using atherosclerosis as a test case, we extracted data from the 2 most common mouse models of atherosclerosis (ApoE [apolipoprotein E]-knockout and LDLR [low-density lipoprotein receptor]-knockout). We restricted analyses to manuscripts published in 2 well-established journals, <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i> and <i>Circulation</i>, as of query in 2021. Predefined variables including experimental conditions, intervention, and outcomes were extracted from each publication to produce a preclinical atherosclerosis database.</p><p><strong>Results: </strong>Extracted data include animal sex, diet, intervention type, and distinct plaque pathologies (size, inflammation, and lipid content). Procedures are provided to standardize data extraction, attribute interventions to specific genes, and transform the database for use with available transcriptomics software. The database integrates hundreds of genes, each directly tested in vivo for causation in a murine atherosclerosis model. The database is provided to allow the research community to perform integrated analyses that reflect the global impact of decades of atherosclerosis investigation.</p><p><strong>Conclusions: </strong>This database is provided as a resource for future interrogation of sub-data sets associated with distinct plaque pathologies, cell type, or sex. We also provide the methods and software needed to expand this data set and apply this approach to the extensive repository of peer-reviewed data utilizing preclinical models to interrogate mechanisms of diverse human diseases.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021141/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Genomic and Precision Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCGEN.123.004397","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Basic scientists have used preclinical animal models to explore mechanisms driving human diseases for decades, resulting in thousands of publications, each supporting causative inferences. Despite substantial advances in the mechanistic construct of disease, there has been limited translation from individual studies to advances in clinical care. An integrated approach to these individual studies has the potential to improve translational success.
Methods: Using atherosclerosis as a test case, we extracted data from the 2 most common mouse models of atherosclerosis (ApoE [apolipoprotein E]-knockout and LDLR [low-density lipoprotein receptor]-knockout). We restricted analyses to manuscripts published in 2 well-established journals, Arteriosclerosis, Thrombosis, and Vascular Biology and Circulation, as of query in 2021. Predefined variables including experimental conditions, intervention, and outcomes were extracted from each publication to produce a preclinical atherosclerosis database.
Results: Extracted data include animal sex, diet, intervention type, and distinct plaque pathologies (size, inflammation, and lipid content). Procedures are provided to standardize data extraction, attribute interventions to specific genes, and transform the database for use with available transcriptomics software. The database integrates hundreds of genes, each directly tested in vivo for causation in a murine atherosclerosis model. The database is provided to allow the research community to perform integrated analyses that reflect the global impact of decades of atherosclerosis investigation.
Conclusions: This database is provided as a resource for future interrogation of sub-data sets associated with distinct plaque pathologies, cell type, or sex. We also provide the methods and software needed to expand this data set and apply this approach to the extensive repository of peer-reviewed data utilizing preclinical models to interrogate mechanisms of diverse human diseases.
背景:几十年来,基础科学家利用临床前动物模型探索人类疾病的发病机制,发表了数以千计的论文,每篇论文都支持因果关系推论。尽管在疾病的机理构建方面取得了重大进展,但从单项研究到临床治疗进展的转化却十分有限。对这些单项研究采取综合方法有可能提高转化的成功率:以动脉粥样硬化为例,我们从两种最常见的动脉粥样硬化小鼠模型(载脂蛋白 E 基因敲除模型和低密度脂蛋白受体基因敲除模型)中提取了数据。我们的分析仅限于截至 2021 年查询时发表在《动脉硬化、血栓与血管生物学》和《循环》这两本权威期刊上的稿件。从每篇论文中提取包括实验条件、干预措施和结果在内的预定义变量,生成临床前动脉粥样硬化数据库:提取的数据包括动物性别、饮食、干预类型和不同的斑块病理(大小、炎症和脂质含量)。结果:提取的数据包括动物性别、饮食、干预类型和不同的斑块病理特征(大小、炎症和脂质含量)。提供了标准化数据提取、将干预归因于特定基因和转换数据库的程序,以便与现有的转录组学软件配合使用。该数据库整合了数百个基因,每个基因都在小鼠动脉粥样硬化模型中直接进行了体内因果关系测试。提供该数据库是为了让研究界进行综合分析,以反映数十年来动脉粥样硬化调查的全球影响:该数据库是一种资源,可供今后查询与不同斑块病理、细胞类型或性别相关的子数据集。我们还提供了扩展该数据集所需的方法和软件,并将这种方法应用到广泛的同行评审数据资源库中,利用临床前模型来研究各种人类疾病的机制。
期刊介绍:
Circulation: Genomic and Precision Medicine is a distinguished journal dedicated to advancing the frontiers of cardiovascular genomics and precision medicine. It publishes a diverse array of original research articles that delve into the genetic and molecular underpinnings of cardiovascular diseases. The journal's scope is broad, encompassing studies from human subjects to laboratory models, and from in vitro experiments to computational simulations.
Circulation: Genomic and Precision Medicine is committed to publishing studies that have direct relevance to human cardiovascular biology and disease, with the ultimate goal of improving patient care and outcomes. The journal serves as a platform for researchers to share their groundbreaking work, fostering collaboration and innovation in the field of cardiovascular genomics and precision medicine.